|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> 制纤菌素 C>> 市场分析报告 |
制纤菌素 C市场分析报告 |
|
Global Market Report of fibrostatin C (CAS 91776-47-5) December 2024 Global Goodpasture Syndrome Treatment Market Growth (Status and Outlook) 2023-2029 ... Pharmaceuticals, Bristol-Myers Squibb, Sandoz, Fibrostatin, Hansa Medical and Acer Therapeutics ... Pharmaceuticals Bristol-Myers Squibb Sandoz Fibrostatin Hansa Medical Acer Therapeutics Global Goodpasture Syndrome Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028 ... Pharmaceuticals, Bristol-Myers Squibb, Sandoz, Fibrostatin, and Hansa Medical, etc. In terms ... Pharmaceuticals Bristol-Myers Squibb Sandoz Fibrostatin Hansa Medical Acer Therapeutics Market ... Global Goodpasture Syndrome Treatment Market Research Report 2024(Status and Outlook) ... Pharmaceuticals Bristol-Myers Squibb Sandoz Fibrostatin Hansa Medical Acer Therapeutics Market ... Global Lupus Nephritis Drugs Industry Market Research Report ... are: Takeda Pharmaceutical Company Limited FibroStatin SL HanAll Biopharma Co., Ltd. Zyrnat Biotherapeutics ... 2023-2028 Global and Regional Goodpasture Syndrome Treatment Industry Status and Prospects Professional Market Research Report Standard Version ... America). By Market Verdors: Amneal Pharmaceuticals Fibrostatin Bristol-Myers Squibb Sandoz Acer ... Non-Small Cell Lung Cancer - Pipeline Review, H2 2017 Non-Small Cell Lung Cancer - Pipeline Review, H2 2017 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer - Pipeline Review, H2 2017, provides an overview of the Non-Small Cell Lung Cancer ... Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2020 Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2020, provides an overview of the Idiopathic Pulmonary ... Non-Small Cell Lung Cancer - Pipeline Review, H1 2020 Non-Small Cell Lung Cancer - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer - Pipeline Review, H1 2020, provides an overview of the Non-Small Cell Lung Cancer ... |